University of North Carolina Dept. of LinbergerCancerCtr(3) — Chapel Hill, North Carolina

University of North Carolina Dept. of LinbergerCancerCtr(3) is a clinical research site located in Chapel Hill, North Carolina, United States 27599-7295.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

University of North Carolina Dept. of LinbergerCancerCtr(3) has participated in 1 clinical trials.

Therapeutic areas: Renal Cell Carcinoma.

Sponsors: Novartis Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University of North Carolina Dept. of LinbergerCancerCtr(3)?

University of North Carolina Dept. of LinbergerCancerCtr(3) has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University of North Carolina Dept. of LinbergerCancerCtr(3) conducted?

University of North Carolina Dept. of LinbergerCancerCtr(3) has 1 clinical trials on record. Their work covers Renal Cell Carcinoma.

Is University of North Carolina Dept. of LinbergerCancerCtr(3) accredited by Crixeo Health?

University of North Carolina Dept. of LinbergerCancerCtr(3) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about University of North Carolina Dept. of LinbergerCancerCtr(3)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.